The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
Clinical trial NCT05132855 · UNKNOWN
Trial details
- NCT number
- NCT05132855
- Sponsor
- Chang Gung Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-04-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.